RCS Healthcare is a global sourcing and distribution company providing high-quality medical and diagnostic products at manufacturer-direct pricing. We support healthcare providers and distributors with reliable procurement, logistics expertise, and tailored healthcare solutions.
-
13 Publicações
-
12 fotos
-
0 Vídeos
-
Reside em Hermosa Beach
-
De Hermosa Beach
-
Male
-
14/09/1997
-
Seguido por 0 pessoas
Pesquisar
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Atualizações Recentes
-
FebriDx® External Controls Novo€51.63In stockUnited States0 AnteriorThe controls kit provides external positive and negative controls designed to assess the performance and reliability of the FebriDx® test in professional settings. Easy to store, simple to run, and aligned with CLIA and manufacturer recommendations, these controls help ensure your results remain accurate, reproducible, and compliant—test after test.
Features and Benefits:
Delivers results after 10 minutes
No equipment necessary
CLIA Waived Test
The controls kit provides external positive and negative controls designed to assess the performance and reliability of the FebriDx® test in professional settings. Easy to store, simple to run, and aligned with CLIA and manufacturer recommendations, these controls help ensure your results remain accurate, reproducible, and compliant—test after test. Features and Benefits: Delivers results after 10 minutes No equipment necessary CLIA Waived Test0 Comentários 0 Compartilhamentos 87 Visualizações 0 Anterior -
WELLlife™ SARS-CoV-2/Flu A+B Rapid Antigen Test Novo€114.76In stockUnited States0 AnteriorWELLlife™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a POC rapid antigen test that detects SARS-CoV-2, influenza A, and influenza B in 10 minutes. This point-of-care immunoassay offers a broader detection window within five days of symptom onset.
Features and Benefits:
Delivers results in 10 minutes
No equipment necessary
Covid-19: PPA 87.5%; NPA 99.7%
Flu A: PPA 85.9%; NPA 99.7%
Flu B: PPA 86.8%; NPA 99.7%
Nasal or nasopharyngeal swab samples
CLIA Waived Test
WELLlife™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a POC rapid antigen test that detects SARS-CoV-2, influenza A, and influenza B in 10 minutes. This point-of-care immunoassay offers a broader detection window within five days of symptom onset. Features and Benefits: Delivers results in 10 minutes No equipment necessary Covid-19: PPA 87.5%; NPA 99.7% Flu A: PPA 85.9%; NPA 99.7% Flu B: PPA 86.8%; NPA 99.7% Nasal or nasopharyngeal swab samples CLIA Waived Test0 Comentários 0 Compartilhamentos 351 Visualizações 0 Anterior -
SAFElife™ 12-Panel C-Cup (CDOA-3124) Novo€55.43In stockUnited States0 AnteriorSAFE life™ 12-Panel C- Cup Multi-Drug Urine Test Cup was designed with your needs in mind. It is a lateral flow chromatographic immunoassay Point-of-Care Test for the simultaneous detection of multiple drugs and drug metabolites in human urine. Cups feature leak-resistant lids and a well at the bottom to allow for testing of a smaller sample volume.
Tests for Amphetamine (AMP), Barbiturates (BAR), Buprenorphine (BUP), Benzodiazepines (BZO), Cocaine (COC), Methylenedioxymethamphetamine (MDMA), Methadone (MTD), Opiate (OPI), Oxycodone (OXY), Phencyclidine (PCP), Tricyclic Antidepressants (TCA), Cannabinoids (THC).SAFE life™ 12-Panel C- Cup Multi-Drug Urine Test Cup was designed with your needs in mind. It is a lateral flow chromatographic immunoassay Point-of-Care Test for the simultaneous detection of multiple drugs and drug metabolites in human urine. Cups feature leak-resistant lids and a well at the bottom to allow for testing of a smaller sample volume. Tests for Amphetamine (AMP), Barbiturates (BAR), Buprenorphine (BUP), Benzodiazepines (BZO), Cocaine (COC), Methylenedioxymethamphetamine (MDMA), Methadone (MTD), Opiate (OPI), Oxycodone (OXY), Phencyclidine (PCP), Tricyclic Antidepressants (TCA), Cannabinoids (THC).0 Comentários 0 Compartilhamentos 192 Visualizações 0 Anterior -
DrySee® Liquid Indicating Bandage (2 x 2 pad) Digital Novo€49.01In stockUnited States0 AnteriorDrySee®’s 2×2 +Pad Dressing is ideal for smaller wounds, cuts, and post-surgery incisions that need to be kept covered and dry. The perimeter liquid intrusion indicator on the waterproof bandage allows the wearer or caretaker to see if the bandage has been compromised from outside moisture. The inner pad liquid indicator will change color to alert that it has become saturated from wound fluid. Bandages can be worn for up to 4 days with no liquid indication.DrySee®’s 2×2 +Pad Dressing is ideal for smaller wounds, cuts, and post-surgery incisions that need to be kept covered and dry. The perimeter liquid intrusion indicator on the waterproof bandage allows the wearer or caretaker to see if the bandage has been compromised from outside moisture. The inner pad liquid indicator will change color to alert that it has become saturated from wound fluid. Bandages can be worn for up to 4 days with no liquid indication.0 Comentários 0 Compartilhamentos 425 Visualizações 0 Anterior -
Status™ Strep A Flip Digital Novo€41.73In stockUnited States0 AnteriorStatus™ Strep A Flip Rapid Point-of-Care Test is a immuno-chromatographic assay for detection of group A streptococcal antigen directly from a throat swab sample.
Features and Benefits:
Innovative Flip Test Design
Patented single-use reagent capsule
Sensitivity 96.0%; Specificity 99.0%
Delivers results within 5 minutes
No counting drops - less steps for greater accuracy
CLIA Waived Test
Status™ Strep A Flip Rapid Point-of-Care Test is a immuno-chromatographic assay for detection of group A streptococcal antigen directly from a throat swab sample. Features and Benefits: Innovative Flip Test Design Patented single-use reagent capsule Sensitivity 96.0%; Specificity 99.0% Delivers results within 5 minutes No counting drops - less steps for greater accuracy CLIA Waived Test0 Comentários 0 Compartilhamentos 721 Visualizações 0 Anterior -
Nano-Check™ RSV Digital Novo€148.54In stockUnited States0 AnteriorThe Nano-Check™ RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) nucleoprotein antigen in anterior nasal swab specimens from patients with signs and symptoms of respiratory infections.
This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients aged 6 months to 6 years old, and adults over 60 years of age.The Nano-Check™ RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) nucleoprotein antigen in anterior nasal swab specimens from patients with signs and symptoms of respiratory infections. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients aged 6 months to 6 years old, and adults over 60 years of age.0 Comentários 0 Compartilhamentos 757 Visualizações 0 Anterior -
Healgen™ Rapid Check RSV w/ PBS Digital Novo€119.75In stockUnited States0 AnteriorHealgen™ Rapid Check RSV w/ PBS is a point-of-care chromatographic immunoassay for the qualitative detection of Respiratory Syncytial Virus (RSV) antigen. It is intended as a screening test and as an aid in the diagnosis of RSV respiratory infections.Healgen™ Rapid Check RSV w/ PBS is a point-of-care chromatographic immunoassay for the qualitative detection of Respiratory Syncytial Virus (RSV) antigen. It is intended as a screening test and as an aid in the diagnosis of RSV respiratory infections.0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior -
CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Test Digital Novo€115.93In stockUnited States0 AnteriorCorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Point-of-Care Test is a lateral flow immunoassay intended for in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from anterior nasal swab specimens obtained from patients who are suspected of COVID-19 by their healthcare provider, within the first five days of onset of symptoms.
Features and Benefits:
SARS-CoV-2/Flu A+B Rapid POC Combo Antigen Test
Simultaneous testing for acute respiratory infections caused by COVID-19, Flu A, Flu B
Lateral flow immunoassay
Covid-19: Sensitivity 89.6%; Specificity 99.8%
Flu A: Sensitivity 85%; Specificity 99.2%
Flu B: Sensitivity 87.5%; Specificity 99.8%
Nasal swab samples
Delivers results within 10 minutes
No equipment necessary
CLIA Waived TestCorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Point-of-Care Test is a lateral flow immunoassay intended for in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from anterior nasal swab specimens obtained from patients who are suspected of COVID-19 by their healthcare provider, within the first five days of onset of symptoms. Features and Benefits: SARS-CoV-2/Flu A+B Rapid POC Combo Antigen Test Simultaneous testing for acute respiratory infections caused by COVID-19, Flu A, Flu B Lateral flow immunoassay Covid-19: Sensitivity 89.6%; Specificity 99.8% Flu A: Sensitivity 85%; Specificity 99.2% Flu B: Sensitivity 87.5%; Specificity 99.8% Nasal swab samples Delivers results within 10 minutes No equipment necessary CLIA Waived Test0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior -
GenBody Rapid COVID-19 Ag Test Digital Novo€67.30In stockUnited States0 AnteriorThe GenBody COVID-19 Ag point-of-care test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
Features & Benefits
FDA EUA Authorized rapid antigen test
Anterior nasal swab specimen collection for comfort
Identifies acute infection with a 92.31% sensitivity and 99.04% specificity
Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
Large manufacturing capacity and immediately available for distribution
For use in the Point-of-Care settingThe GenBody COVID-19 Ag point-of-care test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. Features & Benefits FDA EUA Authorized rapid antigen test Anterior nasal swab specimen collection for comfort Identifies acute infection with a 92.31% sensitivity and 99.04% specificity Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test Large manufacturing capacity and immediately available for distribution For use in the Point-of-Care setting0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior -
KüraGuard Nitrile Gloves Digital Novo€22.37In stockUnited States0 AnteriorKüraGuard nitrile examination gloves have been designed to be hygienic and easy to fit in a range of sizes. Easily identified by their blue violet color, KüraGuard latex-free examination gloves provide protection and comfort in medical environments.
Features and Benefits:
Latex-free formulation
Powder-free to reduce skin sensitivity
Beaded cuff to reduce rips
Compliant with ASTM standards
Fingertip textured
Easy dispensing carton
KüraGuard nitrile examination gloves have been designed to be hygienic and easy to fit in a range of sizes. Easily identified by their blue violet color, KüraGuard latex-free examination gloves provide protection and comfort in medical environments. Features and Benefits: Latex-free formulation Powder-free to reduce skin sensitivity Beaded cuff to reduce rips Compliant with ASTM standards Fingertip textured Easy dispensing carton0 Comentários 0 Compartilhamentos 869 Visualizações 0 Anterior -
FebriDx® Rapid Respiratory Test Digital Novo€532.32In stockUnited States0 AnteriorFebriDx® Rapid Respiratory Test is a rapid point-of-care test that differentiates bacterial infections from non-bacterial pathogens. In 10 minutes, this portable test allows medical providers to initiate the correct treatment and avoid the overuse of antibiotics.
Features and Benefits:
Allows medical providers to identify or rule out bacterial infections
Delivers results within 10 minutes
No equipment necessary
Reduces the need to write antibiotic prescriptions
99% Negative predictive value
CLIA Moderate Waived Test
FebriDx® Rapid Respiratory Test is a rapid point-of-care test that differentiates bacterial infections from non-bacterial pathogens. In 10 minutes, this portable test allows medical providers to initiate the correct treatment and avoid the overuse of antibiotics. Features and Benefits: Allows medical providers to identify or rule out bacterial infections Delivers results within 10 minutes No equipment necessary Reduces the need to write antibiotic prescriptions 99% Negative predictive value CLIA Moderate Waived Test0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Mais Stories